2025 |
NeuroPace Inc
|
Director |
- |
- |
2024 |
Hyperfine Inc - Ordinary Shares - Class A
|
Executive Chairperson of the Board |
- |
- |
2024 |
NeuroPace Inc
|
Director |
- |
- |
2024 |
Envista Holdings Corp
|
Chairman of the Board |
- |
- |
2024 |
QuidelOrtho Corporation
|
Independent Director |
- |
- |
2024 |
Acutus Medical Inc
|
Chairman of the Board |
- |
- |
2023 |
Envista Holdings Corp
|
Chairman of the Board |
435.1 K |
5.7 % |
2022 |
Envista Holdings Corp
|
Chairman of the Board |
411.6 K |
3.4 % |
2022 |
Acutus Medical Inc
|
Chairman of the Board |
181.1 K |
49.7 % |
2022 |
Hyperfine Inc - Ordinary Shares - Class A
|
Executive Chairman of the Board |
- |
- |
2021 |
Hyperfine Inc - Ordinary Shares - Class A
|
Executive Chairman of the Board |
2.7 M |
- |
2021 |
Envista Holdings Corp
|
Chairman of the Board |
398.1 K |
2.0 % |
2021 |
Acutus Medical Inc
|
Chairman of the Board |
121 K |
-32.6 % |
2020 |
Envista Holdings Corp
|
Chairman of the Board |
390.4 K |
60.8 % |
2020 |
Acutus Medical Inc
|
Executive Chairman of the Board |
179.4 K |
-97.7 % |
2020 |
Hyperfine Inc - Ordinary Shares - Class A
|
Executive Chairman of the Board |
- |
- |
2019 |
Acutus Medical Inc
|
Executive Chairman of the Board |
7.9 M |
- |
2019 |
Envista Holdings Corp
|
Chairman of the Board |
242.8 K |
- |
2018 |
Envista Holdings Corp
|
Chairman of the Board |
- |
- |
2015 |
Bellerophon Therapeutics Inc
|
- |
170.5 K |
- |
2015 |
Bellerophon Therapeutics Inc
|
Independent Director |
- |
- |